6533b82efe1ef96bd1292fdc
RESEARCH PRODUCT
86P Patients (pts) preference for different administration methods of trastuzumab (T) in pts with HER2+ early breast cancer (BC) treated within the GAIN-2 trial
F MarméHj LückR.j.c. MahlbergM. AydogduMartina SchmidtN KlutinusMichael UntchElmar StickelerPeter KlareEkkehart LaddaMattea ReinischBruno Valentin SinnSabine SchmatlochVolker MöbusT. ReimerS. LoiblC. JackischT. HitscholdSabine SeilerJ. Reysubject
Oncologymedicine.medical_specialtyOncologyTrastuzumabbusiness.industryInternal medicinemedicineHematologybusinessAdministration (government)Preferencemedicine.drugEarly breast canceryear | journal | country | edition | language |
---|---|---|---|---|
2020-05-01 | Annals of Oncology |